Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

beckman coulter ,inc. s. kraemer blvd.250 92821 brea sad -

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

jasika d.o.o., zagreb - in vitro dijagnostika, reagens kit za hplc analizu

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

jasika d.o.o., zagreb - reagens kit s kontrolama, kalibratorom i kolonom za određivanje lijekova metodom tekućinske kromatografije - masene spektrometri

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

elektroničar d.o.o. karlovačka cesta 26/a 10000 zagreb -

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

biomax d.o.o., zagreb - in vitro dijagnostika za potvrdu anti hiv-2 antitijela, anti hiv-1 antitijela, određivanje antitijela za hcv, određivanje antiti

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

jasika d.o.o., zagreb - in vitro dijagnostika, kvalitativni in vitro nat test za detekciju hiv-1 rnk, hcv rnk i hbv dnk

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

beckman coulter d.o.o., zagreb - in vitro dijagnostički sistem, hematološki brojač, analizator

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

johnson & johnson s.e. d.o.o., zagreb - totalna endoproteza koljena

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

johnson & johnson s.e. d.o.o., zagreb - uzimanje uzoraka, dijagnoza, histološko istraživanje i djelomičnom ili potpunom uklanjanju abnormalnog tkiva dojki

Europska Unija - hrvatski - EMA (European Medicines Agency)

abbvie deutschland gmbh & co. kg - upadacitinib - artritis, reumatoidni - imunosupresivi - rheumatoid arthritisrinvoq is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (dmards). rinvoq may be used as monotherapy or in combination with methotrexate. psoriatic arthritisrinvoq is indicated for the treatment of active psoriatic arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more dmards. rinvoq may be used as monotherapy or in combination with methotrexate. axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)rinvoq is indicated for the treatment of active non-radiographic axial spondyloarthritis in adult patients with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri), who have responded inadequately to nonsteroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)rinvoq is indicated for the treatment of active ankylosing spondylitis in adult patients who have responded inadequately to conventional therapy. atopic dermatitisrinvoq is indicated for the treatment of moderate to severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. ulcerative colitisrinvoq is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.  crohn’s diseaserinvoq is indicated for the treatment of adult patients with moderately to severely active crohn’s disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.